↓ Skip to main content

Advantages and applications of CAR-expressing natural killer cells

Overview of attention for article published in Frontiers in Pharmacology, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs
1 blog
twitter
12 X users
patent
7 patents

Readers on

mendeley
418 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advantages and applications of CAR-expressing natural killer cells
Published in
Frontiers in Pharmacology, February 2015
DOI 10.3389/fphar.2015.00021
Pubmed ID
Authors

Wolfgang Glienke, Ruth Esser, Christoph Priesner, Julia D. Suerth, Axel Schambach, Winfried S. Wels, Manuel Grez, Stephan Kloess, Lubomir Arseniev, Ulrike Koehl

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 418 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 <1%
Turkey 1 <1%
Portugal 1 <1%
France 1 <1%
Unknown 412 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 101 24%
Student > Ph. D. Student 71 17%
Student > Master 62 15%
Student > Bachelor 38 9%
Other 27 6%
Other 58 14%
Unknown 61 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 84 20%
Immunology and Microbiology 75 18%
Agricultural and Biological Sciences 71 17%
Medicine and Dentistry 50 12%
Pharmacology, Toxicology and Pharmaceutical Science 17 4%
Other 43 10%
Unknown 78 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2023.
All research outputs
#1,376,021
of 24,129,125 outputs
Outputs from Frontiers in Pharmacology
#486
of 17,978 outputs
Outputs of similar age
#20,318
of 365,813 outputs
Outputs of similar age from Frontiers in Pharmacology
#4
of 74 outputs
Altmetric has tracked 24,129,125 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,978 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.